03:19:42 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-08-14 Extra Bolagsstämma 2024
2024-05-29 X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2024-08-22 07:00:00
OSLO, NORWAY - 22 August 2024 - Circa Group AS (stock symbol: CIRCA) announced
its second quarter results today. A webinar will be held at 08.30 CET (details
below).

Progress related to the site works and equipment deliveries from suppliers to
site have continued for the ReSoluteTM project. Further site works and project
progress are now pending funding and the environmental permit.

The funding process efforts have continued through the second quarter with
management investigating all options for a solution.

The environmental permitting process continues with strong local authority
support. The public consultation is planned to start in Q3 with the expectation
that the environmental permit will be received during Q4 2024.

This quarter saw a continued management focus on commercial activities aimed at
partnership with distributors, end customers and contract manufacturers.

Q2 also saw the arrival of a new CFO. Erik Berger joined Circa in April and
succeeded the previous CFO on June 1st.

Circa Group AS CEO Bertel Karlstedt said: "The company's increased focus on high
value applications and specialty chemicals facilitates a strong business case
for the future of Circa Group AS with the ResoluteTM unit in France in operation.
The funding process is challenging and needs to find its solution."

For further information, please access the complete Q2 report:
https://circa-group.com/stock- announcements

To join the Q2 results webinar please copy and paste this link into your web
browser:

https://teams.microsoft.com/l/meetup-join/19%3ameeting_OTU3OGYxZDEtYTkxOS00ZTA5L
TgyNGItNGExODUyYWIxN2Vh%40thread.v2/0?context=%7b%22Tid%22%3a%227fe83212-6533-49
bf-96c7-1c50525cb252%22%2c%22Oid%22%3a%225dc15b54-aef2-452f-9784-388ee0ba2bf1%22
%7d


About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio- based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food biomass and addressing a gap in the market by
providing bio-based, less carbon intensive alternatives, contributing to a more
circular economy.
https://circa-group.com


Investor Contact
Erik Berger
Chief Financial Officer Circa Group AS
erik.berger@circa-group.com
Tel: +47 908 55 033